The Top Five Deals Of 2015 (And A Few That Fell Apart)
This article was originally published in Scrip
It's obvious which transaction (or pending transaction) is deal of the year for 2015 even without being told, right? Of course, it's the $160bn merger between Pfizer Inc. and Allergan PLC, not just because it will create the biggest pharma company and the biggest health care company in the world, but also because of the deals that had to occur for the merger to make sense and because of the deals that may follow on its heels in 2016.
Register for our free email digests: